Reply to NICE says drug for metastatic breast cancer is unaffordable for NHSdoi:http://dx.doi.org/10.1136/bmj.g2888BMJ
Digestive Disease, Copenhagen, Denmark; 6Digestive Disease Center, Centre for Epidemiology and Biostatistics, Norwegian University of Life Sciences, Oslo, Norway Aims: The aim of this study was to compare the efficacy and tolerability of BP-C1 vs equal- looking placebo in metastatic breast cancer....
Molecular profiling of circulating extracellular vesicles (EVs) provides a promising noninvasive means to diagnose, monitor, and predict the course of metastatic breast cancer (MBC). However, the analysis of EV protein markers has been confounded by the presence of soluble protein counterparts in peri...
Jane L. Meisel, MD, shares data from a study on communication challenges between providers and patients with metastatic breast cancer regarding TRAEs. This is a modal window. The Playback API request failed for an unknown reason Error Code: VIDEO_CLOUD_ERR_UNKNOWN Technical details : Unknown ...
Barbara Pistilli, MD, discusses the importance of understanding how HER2 expression can change over time when assessing target expression in metastatic breast cancer.
the TCGA project. For example, the classification of breast, thyroid, colorectal, and rectal cancers all showed an AUC value >0.97 (Supplementary Table4; Fig.4c). BELIVE showed a relatively poor performance for esophagus cancer with an AUC of 0.92, probably due to tumor heterogeneity51,52,53...
2023, Nature Reviews Cancer The evolving role of tissue-resident memory T cells in infections and cancer 2022, Science Advances CD39<sup>+</sup> tissue-resident memory CD8<sup>+</sup> T cells with a clonal overlap across compartments mediate antitumor immunity in breast cancer 2022, Science ...
Metastasis is the leading cause of cancer-related deaths of breast cancer patients. Some cancer cells in a tumour go through successive steps, referred to
Ian Krop, MD, PhD, discusses findings from the phase 3 DESTINY-Breast02 trial in patients with HER2-positive metastatic breast cancer.This is a modal window. The Playback API request failed for an unknown reasonError Code: VIDEO_CLOUD_ERR_UNKNOWNTechnical details : Unknown catalog request erro...
Ian E. Krop, MD, PhD, discusses progress made in 2021 in the management of HER2-positive breast cancer. This is a modal window. The Playback API request failed for an unknown reason Error Code: VIDEO_CLOUD_ERR_UNKNOWN Technical details : Unknown catalog request error. Session ID: 2025...